Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Multicentre clinical trial to evaluate the analgesic efficacy and safety of Dexketoprofen (50 mg iv single dose, followed by oral dose of 25 mg t.i.d.) vs. Metamizol [dipyrone] (2 g iv single dose, and 575 mg t.i.d oral) for the treatment of pain subsequent to ambulatory surgery

Trial Profile

Multicentre clinical trial to evaluate the analgesic efficacy and safety of Dexketoprofen (50 mg iv single dose, followed by oral dose of 25 mg t.i.d.) vs. Metamizol [dipyrone] (2 g iv single dose, and 575 mg t.i.d oral) for the treatment of pain subsequent to ambulatory surgery

Status: Completed
Phase of Trial: Phase III

Latest Information Update: 11 Apr 2022

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Most Recent Events

  • 07 Apr 2022 Status changed from active, no longer recruiting to completed.
  • 13 Mar 2008 New trial record.

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top